Norman 'Ned' Sharpless has been named acting head of the Food and Drug Administration.
Norman “Ned”Sharpless, director of the National Cancer Institute, is named acting FDA commissioner.
Azar announced Sharpless’s appointment at a hearing before the House Energy and Commerce Committee’s health subcommittee. “We are going to be carrying forward Dr. Gottlieb’s vision,” he said. “His agenda is my agenda. My agenda is his agenda.” Sharpless was director of the University of North Carolina’s Lineberger Comprehensive Cancer Center before getting the top job at NCI, which is part of the National Institutes of Health. He would be the second cancer institute director to switch to the FDA; the first was Andrew von Eschenbach, who moved to the agency in 2005. Sharpless also founded two biotech companies.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
National Cancer Institute Director Ned Sharpless will be acting FDA commissionerNational Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb steps down from the agency next month, Health and Human Services Secretary Alex Azar said Tuesday.
Read more »
National Cancer Institute Director Ned Sharpless named acting FDA commissionerNational Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb steps down from the agency next month, Health and Human Services Secretary Alex Azar said Tuesday.
Read more »
Silicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley's tech companies like Apple and Alphabet had an ally in FDA commissioner Scott Gottlieb.
Read more »
Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'The FDA warned those using the affected drugs to use alternative precautions to prevent pregnancy.
Read more »
FDA chief Gottlieb's departure might not actually be a good thing for vaping industrySome have called FDA Commissioner Scott Gottlieb's resignation a boon for the e-cigarette industry. It may prove more complicated.
Read more »
Biotech stocks fall after FDA chief Scott Gottlieb resignsThe IBB, an ETF that tracks biotech's biggest players, was down more than 2 percent Wednesday, on pace for its worst day since February 7 when it lost 2.5 percent.
Read more »
FDA Chief Scott Gottlieb to Leave AgencyScott Gottlieb, the Food and Drug Administration commissioner who has presided over initiatives to limit the sale of e-cigarettes to children, is resigning.
Read more »
The New Acting Chief Of The FDA Is A Cancer ScientistNorman 'Ned' Sharpless has publicly supported the agency's policies to curb the use of e-cigarettes.
Read more »
FDA chief Gottlieb resigningWASHINGTON (Reuters) - U.S. Food and Drug Administration chief Scott Gottlieb announced his planned resignation on Tuesday, the Department of Health and Human Services said, and plans to step down in one month. Gottlieb won bipartisan support for his efforts to curb the use of flavored e-cigarettes by
Read more »
Trump FDA chief and vaping foe Scott Gottlieb resignsGottlieb, who'd fought against electronic cigarettes and opioid addiction, is reportedly leaving to spend more time with his family.
Read more »